Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada -EMMA-Can
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
EMMA-Can is a prospective cohort study to assess the safety and effectiveness of MMA-embolization for the treatment of CSDH. Hypothesis- EMMA reduces the recurrence rate of SDH with or without concomitant surgical evacuation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• All patients with subdural hematoma coming to the emergency room or to neurosurgical outpatient clinic
Locations
Other Locations
Canada
Health Sciences centre
RECRUITING
Winnipeg Mb
Contact Information
Primary
Jai Shankar, MD
shivajai1@gmail.com
4313734164
Backup
Susan Alcock, RN
salcock@hsc.mb.ca
2047893669
Time Frame
Start Date: 2021-05-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Embolization of Middle Meningeal Artery for Subdural Hematoma
All patients with CSDH will undergo embolization of Middle Meningeal artery
Related Therapeutic Areas
Sponsors
Leads: University of Manitoba